Pupillary light reflex may predict suicide risk in psychiatric patients, Study.

Written By :  Dr. Shivi Kataria
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-09-06 03:30 GMT   |   Update On 2021-09-06 03:30 GMT

Suicide remains highly prevalent in patients with psychotic and mood disorders. An impediment to suicide prevention efforts is the lack of practical biomarkers of imminent risk of suicidal ideation/behavior/death (SIB).In this regard, it has been suggested that hyperarousal—a state of increased physiologic arousal, which may manifest as insomnia, hypervigilance, agitation,...

Login or Register to read the full article

Suicide remains highly prevalent in patients with psychotic and mood disorders. An impediment to suicide prevention efforts is the lack of practical biomarkers of imminent risk of suicidal ideation/behavior/death (SIB).

In this regard, it has been suggested that hyperarousal—a state of increased physiologic arousal, which may manifest as insomnia, hypervigilance, agitation, and/or irritability—is mediated in part by both noradrenergic (NE) and cholinergic (ACh) systems and a potential marker for SIB.

A study published in Schizophrenia Research journal by Brian J. Miller et al. indicates that the pupillary light reflex (PLR) is a candidate marker of physiologic arousal, as proximal control of pupillary constriction and dilation is governed by acetylcholine (Ach) and norepineohrine (NE), respectively.

The researchers recruited 26 patients with schizophrenia and 42 with major depressive disorder (MDD) age 18–60 years. None of the subjects had a history of alcohol or substance use disorder, and all were free of medications with strong effects on the NE or ACh systems. 2 patients with schizophrenia were psychotropic-free, 4 were treated with first-generation and 20 with non-clozapine second-generation antipsychotics.

11 patients with schizophrenia were treated with antidepressants (8 on SSRIs, two on SNRIs, and one on bupropion). Patients completed the Columbia Suicide Severity Rating Scale (C-SSRS). PLR was measured. Patients were subcategorized based on "ever attempted suicide" (yes/no), as well as "currently suicidal" (yes/no) status based on the CSSRS (lifetime suicide attempts and a score > 0 for the suicidal ideation subscale, respectively).

Patients with schizophrenia had significantly smaller initial and end pupil diameters compared to patients with MDD, but otherwise there were no differences in PLR parameters between subject groups.

"Currently suicidal" versus "not currently suicidal" patients with schizophrenia or MDD had significantly smaller end pupil diameter and faster pupillary average constriction velocity (ACV) (p < 0.01).

In logistic regression models controlling for age, sex, race, and diagnosis, faster ACV was a significant indicator of both "currently suicidal" and "ever attempted suicide" status. Among subjects with no prior suicide attempts, both faster ACV and MCV were significant indicators of "currently suicidal" status.

The findings support the feasibility of using pupillometry to investigate the PLR as an easily-obtained, rapidly-acquired, objective, potential point-of-care test for SIB that can supplement clinical management.

The same team of researchers had recently demonstrated that faster pupillary maximum constriction velocity (MCV), measured by the PLR, was a significant predictor of "ever suicidal" versus "never suicidal" status in patients with MDD and controls. Longitudinal studies are needed to investigate whether the PLR is a mutable indicator of SIB, towards better suicide prevention.

Source: Schizophrenia research: doi: 10.1016/j.schres.2021.06.027


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News